MEDILOG CONSULTING
0679.675.931 · rovalta.com · 25/09/2026
MEDILOG CONSULTING
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOMEDILOG CONSULTING is a Private limited company incorporated in 2017. Its main activity is: Management consultancy activities. Its registered office is in Ellezelles.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0679.675.931
- Incorporation
- 08/08/2017
- Legal form
- Private limited company
- Registered office
- Place 16
7890 Ellezelles · WallonieSee on map - Contributed capital
- 38 165,21 €
- Latest accounts
- 31/12/2025
Joint committees (2)
- 100
- 200
Financials
Source · NBB, 9 filingsTrend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 289,6 k € | +47.8% | 195,9 k € | -13.1% | 225,5 k € | +27.7% | 176,6 k € | -18.7% | 217,3 k € |
| EBITDA | 260,6 k € | +91.0% | 136,5 k € | -33.5% | 205,2 k € | +30.0% | 157,9 k € | -17.3% | 190,8 k € |
| Operating result | 215,3 k € | +126% | 95,3 k € | -42.6% | 166,1 k € | +42.1% | 116,9 k € | -15.3% | 138 k € |
| Net result | 151,9 k € | +125% | 67,6 k € | -69.1% | 218,9 k € | +150% | 87,7 k € | -6.2% | 93,5 k € |
| Balance sheet | |||||||||
| Equity | 658,3 k € | +8.0% | 609,7 k € | -12.7% | 698,2 k € | +31.5% | 530,9 k € | -0.1% | 531,5 k € |
| Total assets | 830,7 k € | +16.9% | 710,8 k € | -15.4% | 839,9 k € | +27.4% | 659,3 k € | +16.6% | 565,3 k € |
| Cash | 196,8 k € | +55.2% | 126,8 k € | -65.6% | 368,4 k € | +41.1% | 261 k € | +41.4% | 184,6 k € |
| Debts | 172,4 k € | +70.5% | 101,1 k € | -28.7% | 141,8 k € | +10.4% | 128,4 k € | +279% | 33,8 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20253 active · 6 ended
Active mandates
Ended mandates
Other companies at this address
Place 16 7890 Ellezelles| Company | CBE no. |
|---|---|
HCD Management● Active | 0745.407.386 |
MEDILOG GxP● Active | 1011.137.797 |
PHARMUNY● Active | 0443.874.077 |
VBS Consulting● Active | 1032.079.307 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 22/06/2026 | 12/06/2025 | 25/06/2024 | 25/08/2023 | 15/06/2022 | 27/07/2021 |
| General meeting | 23/05/2026 | 24/05/2025 | 25/05/2024 | 27/05/2023 | 28/05/2022 | 22/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 9 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 23/05/2026 | 22/06/2026 | French | |
| Micro model | 31/12/2024 | 24/05/2025 | 12/06/2025 | French | |
| Micro model | 31/12/2023 | 25/05/2024 | 25/06/2024 | French | |
| Micro model | 31/12/2022 | 27/05/2023 | 25/08/2023 | French | |
| Micro model | 31/12/2021 | 28/05/2022 | 15/06/2022 | French | |
| Abridged model | 31/12/2020 | 22/05/2021 | 27/07/2021 | French | |
| Abridged model | 31/12/2019 | 23/05/2020 | 26/10/2020 | French | |
| Abridged model | 31/12/2018 | 25/05/2019 | 24/06/2019 | French | |
| Abridged model | 31/12/2017 | 26/05/2018 | 13/07/2018 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20253 active · 6 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Restructuring19/07/2024OBJET - CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring29/05/2024RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates22/12/2023STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - DENOMINATION - DEMISSIONS, NOMINATIONS
- Mandates21/12/2021DEMISSIONS, NOMINATIONS
- Capital / shares17/01/2018CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Other10/08/2017RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025151,9 k €↑
- 2024Annual accounts 202467,6 k €↓
- 2023Annual accounts 2023218,9 k €↑
- 2022Annual accounts 202287,7 k €↓
- 2021Annual accounts 202193,5 k €↑
- 2020Annual accounts 202083,7 k €↑
- 2019Annual accounts 201978,8 k €↑
- 2018Annual accounts 201851,7 k €↓
- 2017Annual accounts 201788,4 k €
- 08/08/2017IncorporationPrivate limited company